DIN 02368676 — TRIESENCE 40 MG
TRIESENCE is a suspension of Triamcinolone Acetonide marketed by NOVARTIS PHARMACEUTICALS CANADA INC. The full Triamcinolone Acetonide monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02368676
- Brand name
- TRIESENCE
- Active ingredient
- Triamcinolone Acetonide
- Strength
- 40 MG
- Dosage form
- SUSPENSION
- Route
- INTRAVITREAL
- Manufacturer
- NOVARTIS PHARMACEUTICALS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Corticosteroid (glucocorticosteroid) formulated as an intravitreal ophthalmic visualization agent
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Triamcinolone Acetonide products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 01999761 | KENALOG-10 INJECTION | 10 MG | SUSPENSION | BRISTOL-MYERS SQUIBB CANADA | MARKETED |
| 01999869 | KENALOG-40 INJECTION | 40 MG | SUSPENSION | BRISTOL-MYERS SQUIBB CANADA | MARKETED |
| 01977563 | TRIAMCINOLONE ACETONIDE INJECTABLE SUSPENSION USP | 40 MG | SUSPENSION | STERIMAX INC | MARKETED |
| 01977555 | TRIAMCINOLONE DIACETATE SUSPENSION | 40 MG | SUSPENSION | STERIMAX INC | DORMANT |